Mwanzo1177 • HKG
add
Sino Biopharmaceutical Ltd
Bei iliyotangulia
$ 2.88
Bei za siku
$ 2.84 - $ 2.90
Bei za mwaka
$ 2.29 - $ 4.25
Thamani ya kampuni katika soko
53.96B HKD
Wastani wa hisa zilizouzwa
52.74M
Uwiano wa bei na mapato
12.18
Mgao wa faida
2.09%
Ubadilishanaji wa msingi
HKG
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 7.94B | 11.14% |
Matumizi ya uendeshaji wa biashara | 4.78B | 10.58% |
Mapato halisi | 1.51B | 139.69% |
Kiwango cha faida halisi | 19.01 | 115.78% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.98B | 8.88% |
Asilimia ya kodi ya mapato | 16.99% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 13.18B | -15.93% |
Jumla ya mali | 66.70B | 1.62% |
Jumla ya dhima | 24.58B | -15.76% |
Jumla ya hisa | 42.12B | — |
hisa zilizosalia | 18.21B | — |
Uwiano wa bei na thamani | 1.60 | — |
Faida inayotokana na mali | 6.50% | — |
Faida inayotokana mtaji | 8.37% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.51B | 139.69% |
Pesa kutokana na shughuli | 1.54B | 15.25% |
Pesa kutokana na uwekezaji | -1.02B | 49.91% |
Pesa kutokana na ufadhili | -2.05B | -1.42% |
Mabadiliko halisi ya pesa taslimu | -1.52B | 43.37% |
Mtiririko huru wa pesa | 1.09B | 36.59% |
Kuhusu
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2000
Tovuti
Wafanyakazi
24,437
